[
  {
    "ts": "2026-01-20T13:36:00+00:00",
    "headline": "Should You Still Hold GMED Stock in Your Portfolio?",
    "summary": "Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.",
    "url": "https://finance.yahoo.com/news/still-hold-gmed-stock-portfolio-133600676.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d7f29908-1f1f-3c07-9211-3e4a757bdb77",
      "content": {
        "id": "d7f29908-1f1f-3c07-9211-3e4a757bdb77",
        "contentType": "STORY",
        "title": "Should You Still Hold GMED Stock in Your Portfolio?",
        "description": "",
        "summary": "Globus Medical is growing musculoskeletal market share with new product launches, strong finances and international expansion plans.",
        "pubDate": "2026-01-20T13:36:00Z",
        "displayTime": "2026-01-20T13:36:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/still-hold-gmed-stock-portfolio-133600676.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/still-hold-gmed-stock-portfolio-133600676.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMED"
            },
            {
              "symbol": "NVST"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-20T10:52:33+00:00",
    "headline": "3 takeaways from Boston Scientific’s $14.5B Penumbra deal",
    "summary": "Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.",
    "url": "https://www.medtechdive.com/news/boston-scientific-penumbra-deal-takeaways/809988/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "5b981714-652d-3a61-af00-bdb64dd7b59f",
      "content": {
        "id": "5b981714-652d-3a61-af00-bdb64dd7b59f",
        "contentType": "STORY",
        "title": "3 takeaways from Boston Scientific’s $14.5B Penumbra deal",
        "description": "",
        "summary": "Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.",
        "pubDate": "2026-01-20T10:52:33Z",
        "displayTime": "2026-01-20T10:52:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/9bc14dd2a3c6cfa5d7078522670b53c0",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Boston Scientific signs on Silicon Valley office, manufacturer of medical devices in San Jose, Calif., March 21, 2021.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D.cjjQyOxG.5HaFjTQLM8w--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/9bc14dd2a3c6cfa5d7078522670b53c0.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oV68u_cDzTaZHU3.l6KktA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/9bc14dd2a3c6cfa5d7078522670b53c0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/boston-scientific-penumbra-deal-takeaways/809988/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-takeaways-boston-scientific-14-105233945.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "PEN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]